Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 3
2007 3
2008 5
2009 8
2010 3
2011 5
2012 2
2013 6
2014 4
2015 6
2016 12
2017 7
2018 9
2019 16
2020 22
2021 28
2022 15
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Cachd1 interacts with Wnt receptors and regulates neuronal asymmetry in the zebrafish brain.
Powell GT, Faro A, Zhao Y, Stickney H, Novellasdemunt L, Henriques P, Gestri G, Redhouse White E, Ren J, Lu W, Young RM, Hawkins TA, Cavodeassi F, Schwarz Q, Dreosti E, Raible DW, Li VSW, Wright GJ, Jones EY, Wilson SW. Powell GT, et al. Among authors: zhao y. Science. 2024 May 3;384(6695):573-579. doi: 10.1126/science.ade6970. Epub 2024 May 2. Science. 2024. PMID: 38696577
Nrf2--a hidden bridge linking cancer stem cells to ferroptosis.
Li Y, Tuerxun H, Liu X, Zhao Y, Wen S, Li Y, Cao J, Zhao Y. Li Y, et al. Among authors: zhao y. Crit Rev Oncol Hematol. 2023 Oct;190:104105. doi: 10.1016/j.critrevonc.2023.104105. Epub 2023 Aug 19. Crit Rev Oncol Hematol. 2023. PMID: 37598896 Review.
Ferroptosis: Reviewing CRC with the Third Eye.
Liu X, Tuerxun H, Li Y, Li Y, He Y, Zhao Y. Liu X, et al. Among authors: zhao y. J Inflamm Res. 2022 Dec 21;15:6801-6812. doi: 10.2147/JIR.S389290. eCollection 2022. J Inflamm Res. 2022. PMID: 36575747 Free PMC article. Review.
Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy.
Jia L, Chen N, Chen X, Niu C, Liu Z, Ma K, Wang N, Yang L, Zhao Y, Song W, Lu J, Chen C, Cong X, Wang X, Xu Y, Cui G, Liu Z, Chen R, Li W, Cui J. Jia L, et al. Among authors: zhao y. Front Immunol. 2022 Dec 8;13:1074906. doi: 10.3389/fimmu.2022.1074906. eCollection 2022. Front Immunol. 2022. PMID: 36569881 Free PMC article. Clinical Trial.
145 results